Unlocking Real-
World Data at Scale

Longitudinal. Real-time. Diverse.

RWD to fuel your R&D

A simple way to access the exact data you need from any number of sites, fast and cost effectively
Patient-level clinical & real-world data available on-demand for drug development, market access and HEOR
Data is matched both onsite (EMRs, PACS, pathology etc.) and between sites, anonymized and standardized to FHIR/ OMOP
Each request is placed on live data, so even as the research evolves, you can continue to zoom in on relevant information for further exploration

Data Quality is Key

Medical innovation goes beyond obtaining RWD. It’s also about the full patient journey.

Often the key to accelerating drug approval or assess drug safety lies in connecting data silos – safely, reliably and compliantly.

To this end, Briya brings game changing technology to the table. 

Briya’s proprietary technology matches patient data across sources with unprecedented accuracy, while maintaining complete patient privacy, to bring you the most comprehensive longitudinal patient records available.

RWD at your fingertips

Access patient-level data from any number of sources, with one simple platform

Global, diverse searchable datasets

access diverse comprehensive data from across the world via one platform

Data specifically tailored to your needs

purchase only the records that you need and pay for them once

Speed-up research

data is extracted in real time, straight from the sources, linked, standerdized & can easily be reused

Unlock insights

hidden in structured and unstructured data, all pieced together to complete patient journeys

Why Briya?

Better data for better research accuracy

More accurate, relevant results provided with our expert AI curation.

Faster, on demand

Receive reliable patient-level data that has been standardized, de-duplicated, and flawlessly linked across multiple sources on demand, in real-time.

Bulletproof privacy & compliance

Smart contracts auto-enforce regulations such as HIPAA and GDPR as well as patient consent and DUA agreements.

How it works?

Unlock RWE across your entire value chain

Market Access
  • Accurate assessment of the market
  • Introduction of a new drug 
  • Post introduction of the drug to the market
  • Vaccine deployment
Clinical Trials
  • Cohort finding; site and patient finding  
  • Pre-study research 
  • RWE control arm 
  • Multi-centered research 
  • EMR supported clinical trials
  •  From clinical trials in
   conditional phase to 
   accelerated approval 
  • Population bridging 
  • Label expansion 
  • Comparative & long- 
   term effectiveness
  • Preparing datasets for 
 AI & ML training 
  • A platform for running 
 AI trials 

Shorten time to data